Skip to main content
Top
Published in: Child's Nervous System 10/2015

01-10-2015 | Special Annual Issue

Functional and neuropsychological late outcomes in posterior fossa tumors in children

Authors: Alvaro Lassaletta, Eric Bouffet, Donald Mabbott, Abhaya V. Kulkarni

Published in: Child's Nervous System | Issue 10/2015

Login to get access

Abstract

Tumors of the posterior fossa (PF) account for up to 60 % of all childhood intracranial tumors. Over the last decades, the mortality rate of children with posterior fossa tumors has gradually decreased. While survival has been the primary objective in most reports, quality of survival increasingly appears to be an important indicator of a successful outcome. Children with a PF tumor can sustain damage to the cerebellum and other brain structures from the tumor itself, concomitant hydrocephalus, the consequences of treatment (surgery, chemotherapy, radiotherapy), or a combination of these factors. Together, these contribute to long-term sequelae in physical functioning, neuropsychological late outcomes (including academic outcome, working memory, perception and estimation of time, and selective attention, long-term neuromotor speech deficits, and executive functioning). Long-term quality of life can also be affected by endocrinological complication or the occurrence of secondary tumors. A significant proportion of survivors of PF tumors require long-term special education services and have reduced rates of high school graduation and employment. Interventions to improve neuropsychological functioning in childhood PF tumor survivors include (1) pharmacological interventions (such as methylphenidate, modafinil, or donepezil), (2) cognitive remediation, and (3) home-based computerized cognitive training. In order to achieve the best possible outcome for survivors, and ultimately minimize long-term complications, new interventions must be developed to prevent and ameliorate the neuro-toxic effects experienced by these children.
Literature
2.
go back to reference Nageswara Rao AA, Packer RJ (2014) Advances in the management of low-grade gliomas. Curr Oncol Rep 16:398CrossRefPubMed Nageswara Rao AA, Packer RJ (2014) Advances in the management of low-grade gliomas. Curr Oncol Rep 16:398CrossRefPubMed
3.
go back to reference Ramaswamy V, Remke M, Adamski J, Bartels U, Tabori U, Wang X, Huang A, Hawkins C, Mabbott D, Laperriere N, Taylor MD, Bouffet E (2015) Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients? Neuro-Oncology. doi:10.1093/neuonc/nou357 PubMed Ramaswamy V, Remke M, Adamski J, Bartels U, Tabori U, Wang X, Huang A, Hawkins C, Mabbott D, Laperriere N, Taylor MD, Bouffet E (2015) Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients? Neuro-Oncology. doi:10.​1093/​neuonc/​nou357 PubMed
4.
go back to reference Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RHA, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JAG, Walker DA, Ellison DW, Machin D (2007) Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. Lancet Oncol 8:696–705CrossRefPubMed Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RHA, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JAG, Walker DA, Ellison DW, Machin D (2007) Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. Lancet Oncol 8:696–705CrossRefPubMed
5.
go back to reference Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA (2009) Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 10:258–266PubMedCentralCrossRefPubMed Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA (2009) Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 10:258–266PubMedCentralCrossRefPubMed
6.
go back to reference Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC (2008) Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 19:178–184CrossRefPubMed Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC (2008) Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 19:178–184CrossRefPubMed
7.
go back to reference Spiegler BJ, Bouffet E, Greenberg M (2004) Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 22:706–713CrossRefPubMed Spiegler BJ, Bouffet E, Greenberg M (2004) Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 22:706–713CrossRefPubMed
8.
go back to reference El-Gaidi MA, El-Nasr AHA, Eissa EM (2015) Infratentorial complications following preresection CSF diversion in children with posterior fossa tumors. J Neurosurg Pediatr 15:4–11CrossRefPubMed El-Gaidi MA, El-Nasr AHA, Eissa EM (2015) Infratentorial complications following preresection CSF diversion in children with posterior fossa tumors. J Neurosurg Pediatr 15:4–11CrossRefPubMed
9.
go back to reference Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Scantlebury N, Law N, Spiegler BJ, Malkin D, Janzen L, Mabbott D (2014) Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J Clin Oncol 32:1760–1768CrossRefPubMed Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Scantlebury N, Law N, Spiegler BJ, Malkin D, Janzen L, Mabbott D (2014) Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J Clin Oncol 32:1760–1768CrossRefPubMed
10.
go back to reference Dias MS, Albright L (1989) Management of hydrocephalus complicating childhood posterior fossa tumors. Pediatr Neurosci 15:283–290CrossRefPubMed Dias MS, Albright L (1989) Management of hydrocephalus complicating childhood posterior fossa tumors. Pediatr Neurosci 15:283–290CrossRefPubMed
11.
go back to reference Due-Tonnessen B, Helseth E (2007) Management of hydrocephalus in children with posterior fossa tumors: role of tumor surgery. Pediatr Neurosurg 43:92–96CrossRefPubMed Due-Tonnessen B, Helseth E (2007) Management of hydrocephalus in children with posterior fossa tumors: role of tumor surgery. Pediatr Neurosurg 43:92–96CrossRefPubMed
12.
go back to reference Reimers TS, Mortensen EL, Schmiegelow K (2007) Memory deficits in long-term survivors of childhood brain tumors may primarily reflect general cognitive dysfunctions. Pediatr Blood Cancer 48:205–212CrossRefPubMed Reimers TS, Mortensen EL, Schmiegelow K (2007) Memory deficits in long-term survivors of childhood brain tumors may primarily reflect general cognitive dysfunctions. Pediatr Blood Cancer 48:205–212CrossRefPubMed
13.
go back to reference Merchant TE, Lee H, Zhu J, Xiong X, Wheeler G, Phipps S, Boop FA, Sanford RA (2004) The effects of hydrocephalus on intelligence quotient in children with localized infratentorial ependymoma before and after focal radiation therapy. J Neurosurg Pediatr 101:159–168CrossRef Merchant TE, Lee H, Zhu J, Xiong X, Wheeler G, Phipps S, Boop FA, Sanford RA (2004) The effects of hydrocephalus on intelligence quotient in children with localized infratentorial ependymoma before and after focal radiation therapy. J Neurosurg Pediatr 101:159–168CrossRef
14.
go back to reference Reimers TS, Ehrenfels S, Mortensen EL, Schmiegelow M, Sonderkaer S, Carstensen H, Schmiegelow K, Muller J (2003) Cognitive deficits in long-term survivors of childhood brain tumors: identification of predictive factors. Med Pediatr Oncol 40:26–34CrossRefPubMed Reimers TS, Ehrenfels S, Mortensen EL, Schmiegelow M, Sonderkaer S, Carstensen H, Schmiegelow K, Muller J (2003) Cognitive deficits in long-term survivors of childhood brain tumors: identification of predictive factors. Med Pediatr Oncol 40:26–34CrossRefPubMed
15.
go back to reference Reeves CB, Palmer S, Reddick WE, et al. (2006) Attention and memory functioning among pediatric patients with medulloblastoma. J Pediatr Psychol 31:272–280CrossRefPubMed Reeves CB, Palmer S, Reddick WE, et al. (2006) Attention and memory functioning among pediatric patients with medulloblastoma. J Pediatr Psychol 31:272–280CrossRefPubMed
16.
go back to reference Konczak J, Schoch B, Dimitrova A, Gizewski ET, Timmann D (2005) Functional recovery of children and adolescents after cerebellar tumour resection. Brain 128:1428–1441CrossRefPubMed Konczak J, Schoch B, Dimitrova A, Gizewski ET, Timmann D (2005) Functional recovery of children and adolescents after cerebellar tumour resection. Brain 128:1428–1441CrossRefPubMed
17.
go back to reference George AP, Kuehn SM, Vassilyadi M, Richards PMP, Parlow SE, Keene DL, Ventureyra ECG (2003) Cognitive sequelae in children with posterior fossa tumors. Pediatr Neurol 28:42–47CrossRefPubMed George AP, Kuehn SM, Vassilyadi M, Richards PMP, Parlow SE, Keene DL, Ventureyra ECG (2003) Cognitive sequelae in children with posterior fossa tumors. Pediatr Neurol 28:42–47CrossRefPubMed
18.
go back to reference Mulhern RK, Palmer S, Merchant T (2005) Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23:5511–5519CrossRefPubMed Mulhern RK, Palmer S, Merchant T (2005) Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23:5511–5519CrossRefPubMed
19.
go back to reference Hirsch JF, Renier D, Czernichow P, Benveniste L, Pierre-Kahn A (1979) Medulloblastoma in childhood. Survival and functional results. Acta Neurochir 48:1–15CrossRefPubMed Hirsch JF, Renier D, Czernichow P, Benveniste L, Pierre-Kahn A (1979) Medulloblastoma in childhood. Survival and functional results. Acta Neurochir 48:1–15CrossRefPubMed
20.
go back to reference Duffner PK, Cohen ME, Thomas P (1983) Late effects of treatment on the intelligence of children with posterior fossa tumors. Cancer 51:233–237CrossRefPubMed Duffner PK, Cohen ME, Thomas P (1983) Late effects of treatment on the intelligence of children with posterior fossa tumors. Cancer 51:233–237CrossRefPubMed
21.
go back to reference Ronning C, Sundet K, Due-Tonnessen B, Lundar T, Helseth E (2005) Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood. Pediatr Neurosurg 41:15–21CrossRefPubMed Ronning C, Sundet K, Due-Tonnessen B, Lundar T, Helseth E (2005) Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood. Pediatr Neurosurg 41:15–21CrossRefPubMed
22.
go back to reference Levisohn L, Cronin-Golomb A, Schmahmann JD (2000) Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain 123:1041–1050CrossRefPubMed Levisohn L, Cronin-Golomb A, Schmahmann JD (2000) Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain 123:1041–1050CrossRefPubMed
23.
go back to reference Scott RB, Stoodley CJ, Anslow P, Paul C, Stein JF, Sugden EM, Mitchell CD (2001) Lateralized cognitive deficits in children following cerebellar lesions. Dev Med Child Neurol 43:685–691CrossRefPubMed Scott RB, Stoodley CJ, Anslow P, Paul C, Stein JF, Sugden EM, Mitchell CD (2001) Lateralized cognitive deficits in children following cerebellar lesions. Dev Med Child Neurol 43:685–691CrossRefPubMed
24.
go back to reference Allen G, Buxton R, Wong E, Courchesne E (1997) Attentional activation of the cerebellum independent of motor involvement. Science 275:1940–1943CrossRefPubMed Allen G, Buxton R, Wong E, Courchesne E (1997) Attentional activation of the cerebellum independent of motor involvement. Science 275:1940–1943CrossRefPubMed
25.
go back to reference Cantelmi D, Schweizer TA, Cusimano MD (2008) Role of the cerebellum in the neurocognitive sequelae of treatment of tumours of the posterior fossa: an update. Lancet Oncol 9:569–576CrossRefPubMed Cantelmi D, Schweizer TA, Cusimano MD (2008) Role of the cerebellum in the neurocognitive sequelae of treatment of tumours of the posterior fossa: an update. Lancet Oncol 9:569–576CrossRefPubMed
26.
27.
go back to reference Leiner HC, Leiner AL, Dow RS (1986) Does the cerebellum contribute to mental skills? Behav Neurosci 100:443–454CrossRefPubMed Leiner HC, Leiner AL, Dow RS (1986) Does the cerebellum contribute to mental skills? Behav Neurosci 100:443–454CrossRefPubMed
28.
go back to reference Riva D, Giorgi C (2000) The cerebellum contributes to higher functions during development: evidence from a series of children surgically treated for posterior fossa tumours. Brain 123:1051–1061CrossRefPubMed Riva D, Giorgi C (2000) The cerebellum contributes to higher functions during development: evidence from a series of children surgically treated for posterior fossa tumours. Brain 123:1051–1061CrossRefPubMed
29.
go back to reference Mabbott DJ, Rovet J, Noseworthy MD, Smith ML, Rockel C (2009) The relations between white matter and declarative memory in older children and adolescents. Brain Res 1294:80–90CrossRefPubMed Mabbott DJ, Rovet J, Noseworthy MD, Smith ML, Rockel C (2009) The relations between white matter and declarative memory in older children and adolescents. Brain Res 1294:80–90CrossRefPubMed
30.
go back to reference Nagel B, Palmer S, Reddick W, Glass J, Helton K, Wu S, Xiong X, Kun L, Gajjar A, Mulhern R (2004) Abnormal hippocampal development in children with medulloblastoma treated with risk-adapted irradiation. AJNR Am J Neuroradiol 25(9):1575–1582PubMed Nagel B, Palmer S, Reddick W, Glass J, Helton K, Wu S, Xiong X, Kun L, Gajjar A, Mulhern R (2004) Abnormal hippocampal development in children with medulloblastoma treated with risk-adapted irradiation. AJNR Am J Neuroradiol 25(9):1575–1582PubMed
31.
go back to reference Riggs L, Bouffet E, Laughlin S, Laperriere N, Liu F, Skocic J, Scantlebury N, Wang F, Schoenhoff NJ, Strother D, Hukin J, Fryer C, McConnell D, Mabbott DJ (2014) Changes to memory structures in children treated for posterior fossa tumors. J Int Neuropsychol Soc 20:168–180CrossRefPubMed Riggs L, Bouffet E, Laughlin S, Laperriere N, Liu F, Skocic J, Scantlebury N, Wang F, Schoenhoff NJ, Strother D, Hukin J, Fryer C, McConnell D, Mabbott DJ (2014) Changes to memory structures in children treated for posterior fossa tumors. J Int Neuropsychol Soc 20:168–180CrossRefPubMed
32.
go back to reference Stargatt R, Rosenfeld JV, Maixner W, Ashley D (2007) Multiple factors contribute to neuropsychological outcome in children with posterior fossa tumors. Dev Neuropsychol 32:729–748CrossRefPubMed Stargatt R, Rosenfeld JV, Maixner W, Ashley D (2007) Multiple factors contribute to neuropsychological outcome in children with posterior fossa tumors. Dev Neuropsychol 32:729–748CrossRefPubMed
33.
go back to reference Ellenberg L, McComb JG, Siegel SE, Stowe S (1987) Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 21:638–644CrossRefPubMed Ellenberg L, McComb JG, Siegel SE, Stowe S (1987) Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 21:638–644CrossRefPubMed
34.
go back to reference Grill J, Renaux VK, Bulteau C, Viguier D, Levy-Piebois C, Sainte-Rose C, Dellatolas G, Raquin M-A, Jambaqua I, Kalifa C (1999) Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 45:137–145CrossRefPubMed Grill J, Renaux VK, Bulteau C, Viguier D, Levy-Piebois C, Sainte-Rose C, Dellatolas G, Raquin M-A, Jambaqua I, Kalifa C (1999) Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 45:137–145CrossRefPubMed
35.
go back to reference Kieffer-Renaux V, Viguier D, Raquin M-A, Laurent-Vannier A, Habrand J-L, Dellatolas G, Kalifa C, Hartmann O, Grill J (2005) Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors. Pediatr Blood Cancer 45:814–819CrossRefPubMed Kieffer-Renaux V, Viguier D, Raquin M-A, Laurent-Vannier A, Habrand J-L, Dellatolas G, Kalifa C, Hartmann O, Grill J (2005) Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors. Pediatr Blood Cancer 45:814–819CrossRefPubMed
36.
go back to reference Thomas PRM, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, Albright L, Allen JC, Packer RJ, Linggood R, Mulhern R, Stehbens JA, Langston J, Stanley P, Duffner P, Rorke L, Cherlow J, Friedman HS, Finlay JL, Vietti TJ, Kun LE (2000) Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18:3004–3011PubMed Thomas PRM, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, Albright L, Allen JC, Packer RJ, Linggood R, Mulhern R, Stehbens JA, Langston J, Stanley P, Duffner P, Rorke L, Cherlow J, Friedman HS, Finlay JL, Vietti TJ, Kun LE (2000) Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18:3004–3011PubMed
37.
go back to reference Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE (1998) Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 16:1723–1728PubMed Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE (1998) Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 16:1723–1728PubMed
38.
go back to reference Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A (2013) Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961. Neuro-Oncology 15:97–103PubMedCentralCrossRefPubMed Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A (2013) Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961. Neuro-Oncology 15:97–103PubMedCentralCrossRefPubMed
39.
go back to reference Steen RG, Koury BSM, Granja CI, Xiong X, Wu S, Glass JO, Mulhern RK, Kun LE, Merchant TE (2001) Effect of ionizing radiation on the human brain: white matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy. Int J Radiat Oncol Biol Phys 49:79–91CrossRefPubMed Steen RG, Koury BSM, Granja CI, Xiong X, Wu S, Glass JO, Mulhern RK, Kun LE, Merchant TE (2001) Effect of ionizing radiation on the human brain: white matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy. Int J Radiat Oncol Biol Phys 49:79–91CrossRefPubMed
40.
go back to reference Goldwein JW, Radcliffe J, Johnson J, Moshang T, Packer RJ, Sutton LN, Rorke LB, D'Angio GJ (1996) Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol Biol Phys 34:899–904CrossRefPubMed Goldwein JW, Radcliffe J, Johnson J, Moshang T, Packer RJ, Sutton LN, Rorke LB, D'Angio GJ (1996) Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol Biol Phys 34:899–904CrossRefPubMed
41.
go back to reference Merchant TE, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley DM, Sexton M, Kellie SJ, Ahern V, Gajjar A (2008) Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys 70:782–787PubMedCentralCrossRefPubMed Merchant TE, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley DM, Sexton M, Kellie SJ, Ahern V, Gajjar A (2008) Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys 70:782–787PubMedCentralCrossRefPubMed
42.
go back to reference Piscione PJ, Bouffet E, Mabbott DJ, Shams I, Kulkarni AV (2014) Physical functioning in pediatric survivors of childhood posterior fossa brain tumors. Neuro-Oncology 16:147–155PubMedCentralCrossRefPubMed Piscione PJ, Bouffet E, Mabbott DJ, Shams I, Kulkarni AV (2014) Physical functioning in pediatric survivors of childhood posterior fossa brain tumors. Neuro-Oncology 16:147–155PubMedCentralCrossRefPubMed
43.
go back to reference Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL, Packer RJ (2009) Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor study. JNCI J Natl Cancer Inst 101:946–958CrossRefPubMed Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL, Packer RJ (2009) Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor study. JNCI J Natl Cancer Inst 101:946–958CrossRefPubMed
44.
go back to reference Mabbott DJ, Spiegler B, Greenberg M, Rutka J, Hyder D, Bouffet E (2005) Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol 23:2256–2263CrossRefPubMed Mabbott DJ, Spiegler B, Greenberg M, Rutka J, Hyder D, Bouffet E (2005) Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol 23:2256–2263CrossRefPubMed
45.
go back to reference Law N, Bouffet E, Laughlin S, Laperriere N, Briere M-E, Strother D, McConnell D, Hukin J, Fryer C, Rockel C, Dickson J, Mabbott D (2011) Cerebello-thalamo-cerebral connections in pediatric brain tumor patients: impact on working memory. NeuroImage 56:2238–2248CrossRefPubMed Law N, Bouffet E, Laughlin S, Laperriere N, Briere M-E, Strother D, McConnell D, Hukin J, Fryer C, Rockel C, Dickson J, Mabbott D (2011) Cerebello-thalamo-cerebral connections in pediatric brain tumor patients: impact on working memory. NeuroImage 56:2238–2248CrossRefPubMed
46.
go back to reference Hetherington R, Dennis M, Spiegler B (2000) Perception and estimation of time in long-term survivors of childhood posterior fossa tumors. J Int Neuropsychol Soc 6:682–692CrossRefPubMed Hetherington R, Dennis M, Spiegler B (2000) Perception and estimation of time in long-term survivors of childhood posterior fossa tumors. J Int Neuropsychol Soc 6:682–692CrossRefPubMed
47.
go back to reference Mabbott DJ, Snyder JJ, Penkman L, Witol A (2009) The effects of treatment for posterior fossa brain tumors on selective attention. J Int Neuropsychol Soc 15:205CrossRefPubMed Mabbott DJ, Snyder JJ, Penkman L, Witol A (2009) The effects of treatment for posterior fossa brain tumors on selective attention. J Int Neuropsychol Soc 15:205CrossRefPubMed
48.
go back to reference Huber JF, Bradley K, Spiegler B, Dennis M (2007) Long-term neuromotor speech deficits in survivors of childhood posterior fossa tumors: effects of tumor type, radiation, age at diagnosis, and survival years. J Child Neurol 22:848–854CrossRefPubMed Huber JF, Bradley K, Spiegler B, Dennis M (2007) Long-term neuromotor speech deficits in survivors of childhood posterior fossa tumors: effects of tumor type, radiation, age at diagnosis, and survival years. J Child Neurol 22:848–854CrossRefPubMed
49.
go back to reference Palmer SL, Leigh L (2009) Survivors of pediatric posterior fossa tumors: cognitive outcome, intervention, and risk-based care. Eur J Oncol Nurs 13:171–178PubMedCentralCrossRefPubMed Palmer SL, Leigh L (2009) Survivors of pediatric posterior fossa tumors: cognitive outcome, intervention, and risk-based care. Eur J Oncol Nurs 13:171–178PubMedCentralCrossRefPubMed
50.
go back to reference Mulhern RK, Palmer SL (2003) Neurocognitive late effects in pediatric cancer. Curr Probl Cancer 27:177–197CrossRefPubMed Mulhern RK, Palmer SL (2003) Neurocognitive late effects in pediatric cancer. Curr Probl Cancer 27:177–197CrossRefPubMed
51.
go back to reference Brinkman TM, Reddick WE, Luxton J, Glass JO, Sabin ND, Srivastava DK, Robison LL, Hudson MM, Krull KR (2012) Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma. Neuro-Oncology 14:iv25–iv36PubMedCentralCrossRefPubMed Brinkman TM, Reddick WE, Luxton J, Glass JO, Sabin ND, Srivastava DK, Robison LL, Hudson MM, Krull KR (2012) Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma. Neuro-Oncology 14:iv25–iv36PubMedCentralCrossRefPubMed
52.
go back to reference Maddrey AM, Bergeron JA, Lombardo ER, McDonald NK, Mulne AF, Barenberg PD, Bowers DC (2005) Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neuro-Oncol 72:245–253CrossRef Maddrey AM, Bergeron JA, Lombardo ER, McDonald NK, Mulne AF, Barenberg PD, Bowers DC (2005) Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neuro-Oncol 72:245–253CrossRef
53.
go back to reference Beebe DW, Ris M, Armstrong F (2005) Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130). J Clin Oncol 23:5198–5204CrossRefPubMed Beebe DW, Ris M, Armstrong F (2005) Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130). J Clin Oncol 23:5198–5204CrossRefPubMed
54.
go back to reference Palmer SL, Hassall T, Evankovich K, Mabbott DJ, Bonner M, Deluca C, Cohn R, Fisher MJ, Morris EB, Broniscer A, Gajjar A (2010) Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro-Oncology 12:1311–1317PubMedCentralPubMed Palmer SL, Hassall T, Evankovich K, Mabbott DJ, Bonner M, Deluca C, Cohn R, Fisher MJ, Morris EB, Broniscer A, Gajjar A (2010) Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro-Oncology 12:1311–1317PubMedCentralPubMed
55.
go back to reference Walsh K, Gioia A, Wells E, Packer R (2014) Long-term neurocognitive functioning in a case series of medulloblastoma survivors: the impact of cerebellar mutism syndrome.. ISPNO meeting, Singapore Walsh K, Gioia A, Wells E, Packer R (2014) Long-term neurocognitive functioning in a case series of medulloblastoma survivors: the impact of cerebellar mutism syndrome.. ISPNO meeting, Singapore
56.
go back to reference Felce D, Perry J (1995) Quality of life: its definition and measurement. Res Dev Disabil 16:51–74CrossRefPubMed Felce D, Perry J (1995) Quality of life: its definition and measurement. Res Dev Disabil 16:51–74CrossRefPubMed
57.
go back to reference Kulkarni AV, Piscione J, Shams I, Bouffet E (2013) Long-term quality of life in children treated for posterior fossa brain tumors. J Neurosurg Pediatr 12:235–240CrossRefPubMed Kulkarni AV, Piscione J, Shams I, Bouffet E (2013) Long-term quality of life in children treated for posterior fossa brain tumors. J Neurosurg Pediatr 12:235–240CrossRefPubMed
58.
go back to reference Bull KS, Spoudeas HA, Yadegarfar G, Kennedy CR (2007) Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG). J Clin Oncol 25:4239–4245CrossRefPubMed Bull KS, Spoudeas HA, Yadegarfar G, Kennedy CR (2007) Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG). J Clin Oncol 25:4239–4245CrossRefPubMed
59.
go back to reference Reimers TS, Mortensen EL, Nysom K, Schmiegelow K (2009) Health-related quality of life in long-term survivors of childhood brain tumors. Pediatr Blood Cancer 53:1086–1091CrossRefPubMed Reimers TS, Mortensen EL, Nysom K, Schmiegelow K (2009) Health-related quality of life in long-term survivors of childhood brain tumors. Pediatr Blood Cancer 53:1086–1091CrossRefPubMed
60.
go back to reference Benesch M, Spiegl K, Winter A, Passini A, Lackner H, Moser A, Sovinz P, Schwinger W, Urban C (2009) A scoring system to quantify late effects in children after treatment for medulloblastoma/ependymoma and its correlation with quality of life and neurocognitive functioning. Childs Nerv Syst 25:173–181CrossRefPubMed Benesch M, Spiegl K, Winter A, Passini A, Lackner H, Moser A, Sovinz P, Schwinger W, Urban C (2009) A scoring system to quantify late effects in children after treatment for medulloblastoma/ependymoma and its correlation with quality of life and neurocognitive functioning. Childs Nerv Syst 25:173–181CrossRefPubMed
61.
go back to reference Chemaitilly W, Li Z, Huang S, Ness KK, Clark KL, Green DM, Barnes N, Armstrong GT, Krasin MJ, Srivastava DK, Pui CH, Merchant TE, Kun LE, Gajjar A, Hudson MM, Robison LL, Sklar CA (2015) Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude lifetime cohort study. J Clin Oncol 33:492–500CrossRefPubMed Chemaitilly W, Li Z, Huang S, Ness KK, Clark KL, Green DM, Barnes N, Armstrong GT, Krasin MJ, Srivastava DK, Pui CH, Merchant TE, Kun LE, Gajjar A, Hudson MM, Robison LL, Sklar CA (2015) Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude lifetime cohort study. J Clin Oncol 33:492–500CrossRefPubMed
62.
go back to reference Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, Morris EB, Sanders RP, Krasin MJ, Shelso J, Xiong Z, Wallace D, Gajjar A (2008) Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol 26:1112–1118CrossRefPubMed Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, Morris EB, Sanders RP, Krasin MJ, Shelso J, Xiong Z, Wallace D, Gajjar A (2008) Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol 26:1112–1118CrossRefPubMed
63.
go back to reference Viswanathan V, Pradhan K, Eugster E (2011) Pituitary hormone dysfunction after proton beam radiation therapy in children with brain tumors. Endocr Pract 17:891–896PubMedCentralCrossRefPubMed Viswanathan V, Pradhan K, Eugster E (2011) Pituitary hormone dysfunction after proton beam radiation therapy in children with brain tumors. Endocr Pract 17:891–896PubMedCentralCrossRefPubMed
64.
go back to reference Merchant TE, C-h H, Shukla H, Ying X, Nill S, Oelfke U (2008) Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 51:110–117CrossRefPubMed Merchant TE, C-h H, Shukla H, Ying X, Nill S, Oelfke U (2008) Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 51:110–117CrossRefPubMed
65.
go back to reference Di Giannatale A, Morana G, Rossi A, Cama A, Bertoluzzo L, Barra S, Nozza P, Milanaccio C, Consales A, Garre ML (2014) Natural history of cavernous malformations in children with brain tumors treated with radiotherapy and chemotherapy. J Neuro-Oncol 117:311–320CrossRef Di Giannatale A, Morana G, Rossi A, Cama A, Bertoluzzo L, Barra S, Nozza P, Milanaccio C, Consales A, Garre ML (2014) Natural history of cavernous malformations in children with brain tumors treated with radiotherapy and chemotherapy. J Neuro-Oncol 117:311–320CrossRef
66.
go back to reference Peterson KM, Shao C, McCarter R, MacDonald TJ, Byrne J (2006) An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors. Pediatr Blood Cancer 47:83–88CrossRefPubMed Peterson KM, Shao C, McCarter R, MacDonald TJ, Byrne J (2006) An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors. Pediatr Blood Cancer 47:83–88CrossRefPubMed
67.
go back to reference Butler RW, Sahler OJZ, Askins MA, Alderfer MA, Katz ER, Phipps S, Noll RB (2008) Interventions to improve neuropsychological functioning in childhood cancer survivors. Dev Disabil Res Rev 14:251–258CrossRefPubMed Butler RW, Sahler OJZ, Askins MA, Alderfer MA, Katz ER, Phipps S, Noll RB (2008) Interventions to improve neuropsychological functioning in childhood cancer survivors. Dev Disabil Res Rev 14:251–258CrossRefPubMed
68.
go back to reference DeLong R, Friedman H, Friedman N, Gustafson K, Oakes J (1992) Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. J Child Neurol 7:462–463CrossRefPubMed DeLong R, Friedman H, Friedman N, Gustafson K, Oakes J (1992) Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. J Child Neurol 7:462–463CrossRefPubMed
69.
go back to reference Meyers CA, Weitzner MA, Valentine AD, Levin VA (1998) Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 16:2522–2527PubMed Meyers CA, Weitzner MA, Valentine AD, Levin VA (1998) Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 16:2522–2527PubMed
70.
go back to reference Thompson SJ, Leigh L, Christensen R, Xiong X, Kun LE, Heideman RL, Reddick WE, Gajjar A, Merchant T, Pui CH, Hudson MM, Mulhern RK (2001) Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol 19:1802–1808PubMed Thompson SJ, Leigh L, Christensen R, Xiong X, Kun LE, Heideman RL, Reddick WE, Gajjar A, Merchant T, Pui CH, Hudson MM, Mulhern RK (2001) Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol 19:1802–1808PubMed
71.
go back to reference Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, Brown R, Xiong X, Wu S, Gururangan S, Reddick WE (2004) Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 22:4795–4803CrossRefPubMed Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, Brown R, Xiong X, Wu S, Gururangan S, Reddick WE (2004) Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol 22:4795–4803CrossRefPubMed
72.
go back to reference Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, Wefel JS (2012) A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neuro-Oncol 107:165–174CrossRef Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, Wefel JS (2012) A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neuro-Oncol 107:165–174CrossRef
73.
go back to reference Rapp SR, Case LD, Peiffer A, Naughton MM, Chan MD, Stieber VW, Moore DF, Falchuk SC, Piephoff JV, Edenfield WJ, Giguere JK, Loghin ME, Shaw EG (2015) Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. J Clin Oncol 33:1953–1959CrossRef Rapp SR, Case LD, Peiffer A, Naughton MM, Chan MD, Stieber VW, Moore DF, Falchuk SC, Piephoff JV, Edenfield WJ, Giguere JK, Loghin ME, Shaw EG (2015) Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. J Clin Oncol 33:1953–1959CrossRef
74.
go back to reference Butler RW, Copeland DR, Fairclough DL, Mulhern RK, Katz ER, Kazak AE, Noll RB, Patel SK, Sahler OJZ (2008) A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 76:367–378PubMedCentralCrossRefPubMed Butler RW, Copeland DR, Fairclough DL, Mulhern RK, Katz ER, Kazak AE, Noll RB, Patel SK, Sahler OJZ (2008) A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 76:367–378PubMedCentralCrossRefPubMed
75.
go back to reference Patel SK, Katz ER, Richardson R, Rimmer M, Kilian S (2009) Cognitive and problem solving training in children with cancer: a pilot project. J Pediatr Hematol Oncol 31:670–677CrossRefPubMed Patel SK, Katz ER, Richardson R, Rimmer M, Kilian S (2009) Cognitive and problem solving training in children with cancer: a pilot project. J Pediatr Hematol Oncol 31:670–677CrossRefPubMed
76.
go back to reference Hardy KK, Willard VW, Allen TM, Bonner MJ (2013) Working memory training in survivors of pediatric cancer: a randomized pilot study. Psycho-Oncology 22:1856–1865PubMedCentralCrossRefPubMed Hardy KK, Willard VW, Allen TM, Bonner MJ (2013) Working memory training in survivors of pediatric cancer: a randomized pilot study. Psycho-Oncology 22:1856–1865PubMedCentralCrossRefPubMed
77.
go back to reference Zou P, Li Y, Conklin HM, Mulhern RK, Butler RW, Ogg RJ (2012) Evidence of change in brain activity among childhood cancer survivors participating in a cognitive remediation program. Arch Clin Neuropsychol 27:915–929PubMedCentralCrossRefPubMed Zou P, Li Y, Conklin HM, Mulhern RK, Butler RW, Ogg RJ (2012) Evidence of change in brain activity among childhood cancer survivors participating in a cognitive remediation program. Arch Clin Neuropsychol 27:915–929PubMedCentralCrossRefPubMed
Metadata
Title
Functional and neuropsychological late outcomes in posterior fossa tumors in children
Authors
Alvaro Lassaletta
Eric Bouffet
Donald Mabbott
Abhaya V. Kulkarni
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 10/2015
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-015-2829-9

Other articles of this Issue 10/2015

Child's Nervous System 10/2015 Go to the issue